TP53 and prostate cancer: Consistently, we observed that the SASP induced a NED in these cells according to both cell morphology and NED marker expression (Figure S3e–h), whereas the SASP did not induce this phenotype in p53 dysfunctional DU145 and PC‐3 prostate cancer cells (Figure S3i).